Miguel A. Calleja
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial.
Journal: PloS one
Published: November 11, 2024
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Journal: Orphanet journal of rare diseases
Published: January 15, 2024
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries.
Journal: Applied health economics and health policy
Published: December 14, 2023
Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.
Journal: Digestive diseases and sciences
Published: May 31, 2023
Results of treatment with alemtuzumab in a Spanish cohort of patients with multiple sclerosis in the real world: The RealMS study.
Journal: Frontiers in neurology
Published: November 30, 2022
Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System: the cefiderocol example.
Journal: International journal of technology assessment in health care
Published: May 20, 2022
Real clinical impact of drug-drug interactions of immunosuppressants in transplant patients.
Journal: Pharmacology research & perspectives
Published: October 18, 2021
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain.
Journal: European journal of hospital pharmacy : science and practice
Published: July 08, 2021
Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System.
Journal: Journal of personalized medicine
Published: April 22, 2021
Potential clinical biomarkers in rheumatoid arthritis with an omic approach.
Journal: Auto- immunity highlights
Published: January 25, 2021
A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study).
Journal: Orphanet journal of rare diseases
Published: October 27, 2020
Last Updated: 09/26/2026